These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 16806496

  • 1. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M, Ikarashi Y, Iizuka A, Kawakami C, Quinn G, Heike Y, Yoshida M, Asaka M, Takaue Y, Wakasugi H.
    Immunol Lett; 2006 Jul 15; 106(1):82-90. PubMed ID: 16806496
    [Abstract] [Full Text] [Related]

  • 2. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y, Iizuka A, Heike Y, Yoshida M, Takaue Y, Wakasugi H.
    Immunol Lett; 2005 Nov 15; 101(2):160-7. PubMed ID: 16054231
    [Abstract] [Full Text] [Related]

  • 3. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y, Iizuka A, Koshidaka Y, Heike Y, Takaue Y, Yoshida M, Kronenberg M, Wakasugi H.
    Immunology; 2005 Sep 15; 116(1):30-7. PubMed ID: 16108815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.
    Infect Immun; 2001 Nov 15; 69(11):6643-50. PubMed ID: 11598033
    [Abstract] [Full Text] [Related]

  • 6. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.
    Ellison CA, Taniguchi M, Fischer JM, Hayglass KT, Gartner JG.
    Immunology; 2006 Nov 15; 119(3):338-47. PubMed ID: 16879624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M, Ilan Y, Ohana M, Safadi R, Alper R, Sherman Y, Doviner V, Rabbani E, Engelhardt D, Nagler A.
    Bone Marrow Transplant; 2005 Jan 15; 35(2):191-7. PubMed ID: 15558045
    [Abstract] [Full Text] [Related]

  • 11. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.
    Nat Med; 2001 Sep 15; 7(9):1057-62. PubMed ID: 11533711
    [Abstract] [Full Text] [Related]

  • 12. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T.
    Immunol Lett; 2004 Aug 15; 95(1):5-11. PubMed ID: 15325792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    Williamson E, Garside P, Bradley JA, More IA, Mowat AM.
    J Immunol; 1997 Aug 01; 159(3):1208-15. PubMed ID: 9233615
    [Abstract] [Full Text] [Related]

  • 15. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
    Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L.
    Nat Med; 2001 Sep 01; 7(9):1052-6. PubMed ID: 11533710
    [Abstract] [Full Text] [Related]

  • 16. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec 01; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 19. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
    Ilan Y, Ohana M, Pappo O, Margalit M, Lalazar G, Engelhardt D, Rabbani E, Nagler A.
    Transplantation; 2007 Feb 27; 83(4):458-67. PubMed ID: 17318079
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep 27; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.